In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Editorial Board of the European Journal of Heart Failure



Editor-in-Chief
Dirk J. van Veldhuisen, FESC, NL

As of 2015:
Marco Metra, FESC, IT

Cardiology,
The department of Medical and Surgical Specialties, Radiological Sciences and Public Health.
University of Brescia
Cardio-Thoracic Department
Civil Hospital of Brescia
P.le Spedali Civili, 1
25123 Brescia
Italy

Senior Consulting Editors
J.G.F. Cleland FESC, UK
K. Swedberg, FESC, SE
D.J. van Veldhuisen, FESC, NL

Consulting Editors
A. A. Voors, FESC, NL
W. H. van Gilst, FESC, NL

Consulting Managing Editor
G. M. Porter, UK
ejhf.editorialoffice@wiley.com

Managing Editor
F. Dalè, IT
Tel: +39 030 338 4130
ejhf.editorialoffice@wiley.com

Associate Editors

International

A. Ahmed, US
(Epidemiology/Outcomes/Aging)
J. Butler, FESC, US
(Clinical Trials/Acute HF)
K. Damman, NL
(Comorbidities/Epidemiology)
G. Fonarow, US
(Quality/Outcomes)
M. Gheorghiade, US
(Clinical trials/Acute HF/Pharmacology)
B. Greenberg, US
(Acute HF/Clinical trials/Gene Transfer Therapy)
K. Dickstein, FESC, NO
(Electrical Devices)
J. Parissis, GR
(Acute & Advanced HF/Biomarkers/Rehabilitation)
B. Pieske, FESC, AT
(HFpEF)
M. Richards, NZ and SG
J. Riley, FESC, UK
(Nursing/Telemonitoring/Disease Management)
G. Rosano, FESC, UK
(Pharmacology)
P. van der Meer, FESC, NL
(Translational Cardiology/Comorbidities)

Regional

E. Arbustini, FESC, IT
(Heritable Cardiovascular Disease)
L. Badano, FESC, IT
(Imaging/Valve Diseases)
S. Barlera, IT
(Statistics/Clinical Trials)
G. Boriani, FESC, IT
(Arrhythmias/Devices)
C. Ceconi, FESC, IT
(Basic science, Biomarkers)
F. Gaita, IT
(Arrhythmias/Devices)
A. Gavazzi, FESC, IT
(Clinical Cardiology/Outcomes)
G. Iaccarino, FESC, IT
(Basic Science/Biomarkers)
R. Latini, IT
(Biomarkers/Cardiac Imaging/Pharmacology)
M. Lombardi, FESC, IT
(Cardiac Imaging)
A. Mortara, FESC, IT
(Acute HF/Telemonitoring/Autonomic function)
S. Nodari, FESC, IT
(Clinical Cardiology, Quality & Outcomes Research)
F. Oliva, IT
(Transplantation/Acute HF)
L. Padeletti, IT
(Arrhythmias/Devices)
M. Piepoli, FESC, IT
(Cardiopulmonary Exercice Testing/Exercice Physiology/Secondary Prevention)
M. Senni, FESC, IT
(Epidemiology, Diastolic function)
G. Sinagra, FESC, IT
(Genetics & Cardiomyopathies)
G.P. Ussia, IT
(Interventional/Valvular Heart Disease)
G. Vescovo, IT
(Pathophysiology/Pharmacology/Clinical Trials)
M. Volterrani, IT
(Exercice/Clinical Cardiology)

Editorial Board

I. Anand, US
S. Anker, FESC, DE
J.-L. Balligand, FESC, BE
F. Braunschweig, FESC, SE
D. Brutsaert, EFESC, BE
M.L. De Buyzere, BE
G. Cotter, FESC, US
M. Cowie, FESC, UK
U.Dahlström, FESC,  SE
L.J. de Windt, FESC, NL
T. Eschenhagen, FESC, DE
G. Filippatos, FESC, GR
M. Fujita, FESC, JP
J. Ghali, US
G. Hasenfuss, FESC, DE
A.W. Hoes, FESC, NL
R. Hulin, CH 
T. Jaarsma, NFESC, SE
J.K. Kjekshus, FESC, NO
M. Komajda, FESC, FR
H. Krum, FESC, AU
A. Maggioni, FESC, IT 
H. McIntyre, FESC, UK
J.J.V. McMurray, FESC, UK
R.J. Mentz, US
W.J. Paulus, FESC, NL
M. Pfeffer, FESC, US
P. Ponikowski, FESC, PL 
L. Ryden, FESC, SE
H. Schunkert, DE 
A.J. Shah, FESC, UK 
K. Sliwa, FESC, ZA
S. Stewart, NFESC, AU
A. Strömberg, NFESC, SE
L. Tavazzi, FESC, IT
C. Torp-Pedersen, FESC, DK
M. Vaduganathan, US
C. M. Yu, FESC, Hong Kong PRC
F. Zannad, FESC, FR